# Japan Tobacco

Japan Tobacco is a Corporate Investor based in Tokyo, Japan.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Tokyo, Japan
- **Region:** Asia
- **Address:** 1-1, Toranomon 4-chome, Minato-ku, Tokyo, Japan
- **Founded:** 1985
- **Assets under management:** Undisclosed
- **Website:** jt.com
- **LinkedIn:** https://www.linkedin.com/company/japan-tobacco-inc-jt
- **Wikidata:** Q898568

## Regulatory record

- **Reports private funds:** No

## About

Japan Tobacco manages Japan.com, a city guide covering Japan's essence and serving as a resource for visitors.

## Sectors

- Consumer Goods
- Pharmaceuticals
- Food & Beverage
- Telecommunications
- Real Estate

## Offices

- Geneva, Switzerland

## People

- Masamichi Terabatake — President, CEO, and Representative Director

## Questions

### Who controls Japan Tobacco's investment decisions?

President and CEO Masamichi Terabatake leads executive decision-making under a board of directors accountable to both public shareholders and the Japanese government. The Minister of Finance holds a mandatory 33-37% stake codified in the JT Incorporation Act, giving the state veto power over resolutions requiring a two-thirds majority. Investment committee structures for specific acquisitions, such as the Manx Telecom deal, involve partners like CVC DIF but ultimately route through JT's corporate governance framework.

### Is Japan Tobacco a sovereign wealth fund or a corporate investor?

JT operates as a publicly traded corporate investor listed on the Tokyo Stock Exchange, not a sovereign wealth fund. However, the government's statutory one-third stake and the firm's origins as a state monopoly blur this line, creating a hybrid entity that serves both commercial and quasi-public mandates. It files public financials and conducts investor relations like any listed consumer-goods company.

### What industries beyond tobacco does JT invest in?

JT's disclosed deployment focuses on three non-tobacco verticals. The pharmaceutical segment pursues clinical-stage assets in metabolic, autoimmune, and rare diseases through partnership and out-licensing models. The processed food business operates under TableMark and Fuji Foods, supplying frozen and shelf-stable products. The firm has also invested in digital infrastructure through its co-investment with CVC DIF, which acquired Manx Telecom Group in 2025.

### What is JT's relationship with Altria Group?

JT and Altria Group have a commercial partnership centered on the U.S. market. The collaboration focuses on commercializing JT's Ploom heated-tobacco product line through Altria's extensive distribution and retail network. This is a strategic business arrangement, not a capital or ownership tie.

### Where does Japan Tobacco's investment capital come from?

JT's capital is funded entirely by retained operating earnings from its global tobacco business, which generated ¥2.9 trillion in revenue in 2024. The pharmaceutical and processed food segments are in development but do not yet contribute materially to free cash flow. The company does not manage external third-party capital and is not structured as a fund.

## Related profiles

- [Japan Post Insurance](https://altss.com/profile/japan-post-insurance)
- [Japanese Red Cross Society Corporate Pension Fund](https://altss.com/profile/japanese-red-cross-society-corporate-pension-fund)

---

Last updated: 2026-07-10T07:20:33.000Z

Canonical page: https://altss.com/profile/japan-tobacco

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology